Microbial Metabolites in Multiple Sclerosis: Implications for Pathogenesis and Treatment.

Area of Science:

• Microbiology
• Immunology
• Neuroscience

Background:

• Gut microbiota metabolites play critical roles in inflammatory, neuropsychiatric, and neurodegenerative diseases.
• Microbial metabolites modulate innate and adaptive immunity, including the generation of regulatory T cells (Tregs).
• Tregs are key regulators in the pathogenesis of multiple sclerosis (MS).

Purpose of the Study:

• To review the role of gut-microbiota derived metabolites in MS pathogenesis.
• To explore these metabolites as potential therapeutic targets for MS.

Main Methods:

• This review synthesizes current research on gut microbiota metabolites and their impact on MS.
• Literature analysis focusing on immune modulation, inflammation, and demyelination in MS.

Main Results:

• Microbial metabolites influence immune cell function relevant to MS.
• These metabolites affect key MS pathological processes like inflammation and demyelination.
• Gut metabolites are implicated as both contributors to disease and potential therapeutic agents.

Conclusions:

• Gut microbiota metabolites are significant factors in MS pathogenesis.
• Targeting these metabolites presents promising therapeutic avenues for MS.
• Further research into microbial metabolites could lead to novel MS treatments.